169 related articles for article (PubMed ID: 30837554)
1. Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial.
Vodstrcil LA; Plummer ME; Fairley CK; Tachedjian G; Law MG; Hocking JS; Worthington MK; Grant MM; Okoko N; Bradshaw CS
Sci Rep; 2019 Mar; 9(1):3555. PubMed ID: 30837554
[TBL] [Abstract][Full Text] [Related]
2. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study.
Ratten LK; Plummer EL; Murray GL; Danielewski J; Fairley CK; Garland SM; Hocking JS; Tachedjian G; Chow E; Bradshaw CS; Vodstrcil LA
BJOG; 2021 Mar; 128(4):756-767. PubMed ID: 33480468
[TBL] [Abstract][Full Text] [Related]
3. Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use.
Bradshaw CS; Vodstrcil LA; Hocking JS; Law M; Pirotta M; Garland SM; De Guingand D; Morton AN; Fairley CK
Clin Infect Dis; 2013 Mar; 56(6):777-86. PubMed ID: 23243173
[TBL] [Abstract][Full Text] [Related]
4. Treating male partners of women with bacterial vaginosis (StepUp): a protocol for a randomised controlled trial to assess the clinical effectiveness of male partner treatment for reducing the risk of BV recurrence.
Vodstrcil LA; Plummer EL; Doyle M; Fairley CK; McGuiness C; Bateson D; Hocking JS; Law MG; Petoumenos K; Donovan B; Chow EPF; Bradshaw CS;
BMC Infect Dis; 2020 Nov; 20(1):834. PubMed ID: 33176727
[TBL] [Abstract][Full Text] [Related]
5. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
[TBL] [Abstract][Full Text] [Related]
6. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.
Bradshaw CS; Morton AN; Hocking J; Garland SM; Morris MB; Moss LM; Horvath LB; Kuzevska I; Fairley CK
J Infect Dis; 2006 Jun; 193(11):1478-86. PubMed ID: 16652274
[TBL] [Abstract][Full Text] [Related]
7. Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.
Plummer EL; Vodstrcil LA; Danielewski JA; Murray GL; Fairley CK; Garland SM; Hocking JS; Tabrizi SN; Bradshaw CS
PLoS One; 2018; 13(1):e0190199. PubMed ID: 29293559
[TBL] [Abstract][Full Text] [Related]
8. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
[TBL] [Abstract][Full Text] [Related]
9. Incident bacterial vaginosis (BV) in women who have sex with women is associated with behaviors that suggest sexual transmission of BV.
Vodstrcil LA; Walker SM; Hocking JS; Law M; Forcey DS; Fehler G; Bilardi JE; Chen MY; Fethers KA; Fairley CK; Bradshaw CS
Clin Infect Dis; 2015 Apr; 60(7):1042-53. PubMed ID: 25516188
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive use in women with bacterial vaginosis.
Shoubnikova M; Hellberg D; Nilsson S; Mårdh PA
Contraception; 1997 Jun; 55(6):355-8. PubMed ID: 9262931
[TBL] [Abstract][Full Text] [Related]
11. Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis.
Plummer EL; Sfameni AM; Vodstrcil LA; Danielewski JA; Murray GL; Fehler G; Fairley CK; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
J Infect Dis; 2023 Aug; 228(5):646-656. PubMed ID: 37427495
[TBL] [Abstract][Full Text] [Related]
12. Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
Balle C; Gill K; Konstantinus IN; Jaumdally SZ; Lennard K; Esra R; Happel AU; Barnabas SL; Gamieldien H; Pidwell T; Maseko V; Lesosky M; Myer L; Passmore JS; Bekker LG; Jaspan HB
Sex Transm Infect; 2021 Mar; 97(2):112-117. PubMed ID: 32989170
[TBL] [Abstract][Full Text] [Related]
13. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome.
Brooks JP; Edwards DJ; Blithe DL; Fettweis JM; Serrano MG; Sheth NU; Strauss JF; Buck GA; Jefferson KK
Contraception; 2017 Apr; 95(4):405-413. PubMed ID: 27913230
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Amsel criteria, Nugent score, culture and two CE-IVD marked quantitative real-time PCRs with microbiota analysis for the diagnosis of bacterial vaginosis.
van den Munckhof EHA; van Sitter RL; Boers KE; Lamont RF; Te Witt R; le Cessie S; Knetsch CW; van Doorn LJ; Quint WGV; Molijn A; Leverstein-van Hall MA
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):959-966. PubMed ID: 30903536
[TBL] [Abstract][Full Text] [Related]
15. Utilization of molecular methods to identify prognostic markers for recurrent bacterial vaginosis.
Hilbert DW; Smith WL; Paulish-Miller TE; Chadwick SG; Toner G; Mordechai E; Adelson ME; Sobel JD; Gygax SE
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):231-42. PubMed ID: 27431434
[TBL] [Abstract][Full Text] [Related]
16. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Indicators of Recurrence of Bacterial Vaginosis.
Sobel JD; Kaur N; Woznicki NA; Boikov D; Aguin T; Gill G; Akins RA
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30842235
[TBL] [Abstract][Full Text] [Related]
18. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
Laue C; Papazova E; Liesegang A; Pannenbeckers A; Arendarski P; Linnerth B; Domig KJ; Kneifel W; Petricevic L; Schrezenmeir J
Benef Microbes; 2018 Jan; 9(1):35-50. PubMed ID: 29065710
[TBL] [Abstract][Full Text] [Related]
19. Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment.
Vodstrcil LA; Muzny CA; Plummer EL; Sobel JD; Bradshaw CS
BMC Med; 2021 Sep; 19(1):194. PubMed ID: 34470644
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence.
Bohbot JM; Daraï E; Bretelle F; Brami G; Daniel C; Cardot JM
J Gynecol Obstet Hum Reprod; 2018 Feb; 47(2):81-86. PubMed ID: 29196153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
